Korro Bio (KRRO) Amortizatization of Intangibles (2023 - 2026)
Korro Bio (KRRO) posted Amortizatization of Intangibles of -$2000.0 for Q1 2026, down 109.09% on a QoQ basis from $22000.0 in Q4 2025, and down 100.59% year-over-year from $340000.0 in Q1 2025.
Korro Bio (KRRO) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Korro Bio's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$2000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 100.59% year-over-year to -$2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147000.0 (down 93.07% YoY) and the FY2025 annual result came in at $489000.0, down 72.56% from the prior year.
- Amortizatization of Intangibles was -$2000.0 for Q1 2026 at Korro Bio, down from $22000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $988000.0 in Q3 2024 and bottomed at -$2000.0 in Q1 2026.
- A 4-year average of $213545.5 and a median of $68000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles soared 98700.0% — and 2026, when it tumbled 100.59%.
- Korro Bio's Amortizatization of Intangibles stood at $1000.0 in 2023, then surged by 62200.0% to $623000.0 in 2024, then plunged by 96.47% to $22000.0 in 2025, then slumped by 109.09% to -$2000.0 in 2026.
- Business Quant data shows KRRO's Amortizatization of Intangibles at -$2000.0 in Q1 2026, $22000.0 in Q4 2025, and $47000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 340,000.00 |
| Mar 31, 2025 | 340,000.00 |
| Dec 31, 2024 | 623,000.00 |
| Dec 31, 2024 | 623,000.00 |
| Sep 30, 2024 | 988,000.00 |
| Sep 30, 2024 | 988,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 11,000.00 |